$5.6 Verdict in Risperdal Case
Janssen Pharmaceuticals, a Johnson & Johnson unit was hit with a $5.6 million dollar verdict. During a clinical study, a young man’s heart abnormalities were allegedly ignored by Janssen, resulting in his death.
More information at the 360Law website.